Biostax Corp (BTAX)

[JSMill]

Naturally - their product IS "news" to pump. If it jumps to 6+ I'll finally (hopefully) be able to short it.

Any "revenue stream" news LOOK FOR A CONTRACT WITH GUARANTEED CASH FLOW. If it's not in there, IT'S NEVER GOING TO HAPPEN.

I say this having spoken to U. MD and Hopkins Oncological Surgeons. The therapies being touted:

1. Only MAY work (slim, they say)
2. Would take a ton of money that they don't have, MILLIONS, to gain approval, while the March 31 Balance Sheet (last one reported) says they have $176 in cash.
3. Even if they do work, their THERAPIES - specific use of a drug - are their only Patents, NOT THE DRUGS THEMSELVES. So that caps the license fees which are their entire PURPORTED revenue plan, as dozens of other SIMILAR therapies are patented as well in the same space.

Summary: The only value TNIB could realize would be FDA approval for THEIR therapy/use of Naltrexone, etc, which would give them at most a WINDOW to make any money, before (again, IF low dose naltrexone works) somebody else gets a "shaken, not stirred" treatment approved as well.

That, OR THIS IS A PURE HYPE PUMP & DUMP. I think many here including myself have laid out many posts on why this is far, far, far more likely, given the financials, history, insiders and press campaign, versus any ACTUAL RESULTS.

Ockham's Razor says Pump & Dump. Beware, Retirees.